Abstract Details
Aravindhan Veerapandiyan, MD
(Arkansas Childrens Hospital/UAMS)
PRESENTER |
Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AMO Pharma, AveXis, Biogen, Edgewise Therapeutics, FibroGen, Novartis, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Scholar Rock, Catalyst, Lupin. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA. |
Vamshi Rao, MD (Ann & Robert H Lurie Children's Hospital) | No disclosure on file |
Janannaz Dastgir, DO (Atlantic health) | Dr. Dastgir has received personal compensation for serving as an employee of Regenxbio. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Team Titin that is relevant to AAN interests or activities. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Hannah's Hope Fund / Gengan Therapeutics that is relevant to AAN interests or activities. |
Paulo Falabella (REGENXBIO Inc) | No disclosure on file |
Steve Pakola | No disclosure on file |
Sarang Rastogi | No disclosure on file |
Dawn Phillips (Regenxbio) | No disclosure on file |
Catherine Wilson (Regenxbio) | No disclosure on file |
Nidal Boulos (REGENXBIO) | No disclosure on file |
Michelle Gilmor | Michelle Gilmor has received personal compensation for serving as an employee of REGENXBIO. Michelle Gilmor has stock in REGENXBIO. |
Lin Yang (Regenxbio) | No disclosure on file |
Hiren Patel (Regenxbio Inc) | No disclosure on file |
Michele Fiscella | No disclosure on file |
Olivier Danos (REGENXBIO) | No disclosure on file |